$Petros Pharmaceuticals(PTPI.US$
needa wait for fda news
needa wait for fda news
$Petros Pharmaceuticals(PTPI.US$
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) has scheduled two meetings with the FDA to review the progress of developing STENDRA as the first PDE-5 inhibitor approved for over-the-counter use. The FDA has requested a listen-only meeting to review the app for improved productivity ahead of a Type C meeting on March 26, 2024, to discuss the development of the digital app and protocols for upcoming studies. Petros believes these meetings highlight the signif...
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) has scheduled two meetings with the FDA to review the progress of developing STENDRA as the first PDE-5 inhibitor approved for over-the-counter use. The FDA has requested a listen-only meeting to review the app for improved productivity ahead of a Type C meeting on March 26, 2024, to discuss the development of the digital app and protocols for upcoming studies. Petros believes these meetings highlight the signif...
3
2
$Petros Pharmaceuticals(PTPI.US$
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
1
$Petros Pharmaceuticals(PTPI.US$
any one has news on the listen only meeting ?
any one has news on the listen only meeting ?
$Trxade Health(MEDS.US$ If you buy in now will youl still be able to recieve the special dividends ?
5
Whitetea
liked
$Petros Pharmaceuticals(PTPI.US$
The AI partnership aligns with Petros's strategy to expand consumer access to prescription medications as OTC options. This move could mark a significant shift in the availability of ED treatments, pending FDA approval.
The AI partnership aligns with Petros's strategy to expand consumer access to prescription medications as OTC options. This move could mark a significant shift in the availability of ED treatments, pending FDA approval.
1